Kong-Teck Chong - Concepedia

Author

Kong-Teck Chong

W.E. Upjohn Institute for Employment Research

Also Known As

Kong-Teck Chong

Publications

Citations

H-Index

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research

About

Kong-Teck Chong is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	578
2	Natural Sciences	6	6	553
3	Biochemistry	6	6	553
4	Chemical Biology	4	4	313
5	Biomolecular Engineering	2	2	123

Kong-Teck Chong

Publications

Citations

H-Index

Page 1

	Year	Citations
Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class Steve R. Turner, Joseph W. Strohbach, Rubén Tommasi, Journal of Medicinal Chemistry	1998	293
Structure-Based Design of HIV Protease Inhibitors: 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Non-peptidic Inhibitors Suvit Thaisrivongs, Paul K. Tomich, Keith David Watenpaugh, Journal of Medicinal Chemistry Hiv Protease InhibitorsAltmetric Attention ScorePharmacotherapyAntiviral DrugPharmaceutical Chemistry	1994	152
Structure-Based Design of Novel HIV Protease Inhibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Nonpeptidic Inhibitors Suvit Thaisrivongs, Keith David Watenpaugh, W. Jeffrey Howe, Journal of Medicinal Chemistry	1995	121
Structure-Based Design of HIV Protease Inhibitors: Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors Suvit Thaisrivongs, Harvey I. Skulnick, Steve R. Turner, Journal of Medicinal Chemistry Hiv Protease InhibitorsPharmacotherapyAntiviral DrugChemical BiologyDrug Metabolism Research	1996	96
Structure-Based Design of Novel HIV Protease Inhibitors: Sulfonamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Non-Peptidic Inhibitors Suvit Thaisrivongs, Musiri N. Janakiraman, Kong-Teck Chong, Journal of Medicinal Chemistry Hiv Protease InhibitorsPeptide ScienceAntiviral DrugPharmaceutical ChemistryMolecular Pharmacology	1996	88
Structure-Based Design of HIV Protease Inhibitors: 5,6-Dihydro-4-hydroxy-2-pyrones as Effective, Nonpeptidic Inhibitors Suvit Thaisrivongs, Donna L. Romero, Rubén Tommasi, Journal of Medicinal Chemistry Crystal StructureBioorganic ChemistryAntiviral DrugChemical BiologyMedicinal Chemistry	1996	86
Structure-Based Design of Nonpeptidic HIV Protease Inhibitors: The Sulfonamide-Substituted Cyclooctylpyranones Harvey I. Skulnick, Paul D. Johnson, Paul A. Aristoff, Journal of Medicinal Chemistry Combinatorial ChemistryAntiviral DrugChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	1997	85
Cycloalkylpyranones and Cycloalkyldihydropyrones as HIV Protease Inhibitors: Exploring the Impact of Ring Size on Structure−Activity Relationships Karen R. Romines, Jeanette K. Morris, W. Jeffrey Howe, Journal of Medicinal Chemistry Hiv Protease InhibitorsCell CultureAntiviral DrugChemical BiologyPharmaceutical Chemistry	1996	46
Non-peptidic HIV protease inhibitors: C2-symmetry-based design of bis-sulfonamide dihydropyrones Musiri N. Janakiraman, Keith David Watenpaugh, Paul K. Tomich, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryAntiviral CompoundBiomolecular EngineeringDrug Discovery	1998	27
Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosine1This paper was presented in part at the Tenth International Conference on AIDS, Yokohama, Japan, August 1994. Abstract No. PAO-314.1 Kong-Teck Chong, Paul Pagano Antiviral Research Didanosine1this PaperMedicineHuman RetrovirusImmunologyAntiviral Drug Development	1997	15

Page 1